U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07000747) titled 'Molecular and Cellular Basis of Severe Forms of Dengue in Sickle Cell Patients' on May 21.
Brief Summary: Dengue virus (DENV) belongs to the genus of Flavivirus transmitted by the mosquito Aedes aegypti and is responsible for an infectious disease associated with different forms and severities such as dengue hemorrhagic fever or shock syndrome. Several recent reports have shown that sickle cell patients exhibited an increased risk of developing severe forms of dengue episodes compared to non-sickle cell subjects. Furthermore, among major sickle cell syndromes, these studies suggest that SC patients are at the highest risk of death du...